How can oncologists collaborate to improve cancer care in Asia? To answer this, Lucence organized a focused medical roundtable meeting for oncologists in Hong Kong. Held on October 4, 2018 at the Island Shangri-La Hotel, our CEO and Medical Director Dr Min-Han Tan presented on “Innovations in Companion Diagnostics for Cancer Care in Asia”. This was followed by a group discussion on how Lucence could contribute to clinical trials for five types of cancers in Hong Kong.
Lucence is committed towards enabling earlier detection and treatment of cancer in Asia. This includes supporting clinical research in genomic medicine and bridging top cancer centers in Asia and the Greater Bay Area.